Polycythemia vera-associated acquired von Willebrand syndrome despite near-normal platelet count

American Journal of Hematology

Volumn 85, Issue 7, 2010, Pages 545-

  Tefferi, Ayaew ^a   Smock, Kristi J ^c   Divgi, Ajit B ^b  

^a MAYO CLINIC   (United States)

^b ARUP LABORATORIES   (United States)

^c Oncology Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; RISTOCETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGAR GEL ELECTROPHORESIS; BLEEDING TENDENCY; CASE REPORT; DISEASE ASSOCIATION; HUMAN; LETTER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTHEMIA; THROMBOCYTOSIS; VON WILLEBRAND DISEASE; WESTERN BLOTTING; BLOOD; MIDDLE AGED; PROTEIN MULTIMERIZATION;

HUMANS; MIDDLE AGED; PLATELET COUNT; POLYCYTHEMIA VERA; PROTEIN MULTIMERIZATION; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 77954941157     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21730     Document Type: Letter

References (11)

1. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005;128:275-290.
2. Nichols WL, Rick ME, Ortel TL, et al. Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol. 2009;84:366-370.
3. Tefferi A, Nichols WL. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis, and treatment. Am J Med 1997;103:536-540.
4. Panzer S, Badr Eslam R, Schneller A, et al. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis. Thromb Haemost 2010;103:408-414.
5. Tiede A, Priesack J, Werwitzke S, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: A retrospective single-centre cohort study. J Thromb Haemost 2008;6:569-576.
6. Fabris F, Casonato A, Grazia del Ben M, et al. Abnormalities of von Willebrand factor in myeloproliferative disease: A relationship with bleeding diathesis. Br J Haematol 1986;63:75-83.
7. Mohri H. Acquired von Willebrand disease in patients with polycythemia rubra vera. Am J Hematol 1987;26:135-146.
8. Budde U, Dent JA, Berkowitz SD, et al. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986;68:1213-1217.
9. Budde U, Scharf RE, Franke P, et al. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993;82:1749-1757.
10. van Genderen PJ, Budde U, Michiels JJ, et al. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count. Br J Haematol 1996;93:962-965.
11. Shim K, Anderson PJ, Tuley EA, et al. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 2008;111:651-657.